Valneva SE (VALN) Return on Capital Employed (2022 - 2026)

Valneva SE (VALN) posted quarterly Return on Capital Employed of 34.27% for Q1 2026, down 1847.0% year-on-year from 1.96% in Q1 2025, and down 37.9% on a QoQ basis from 24.85% in Q4 2025.

Valneva SE (VALN) Return on Capital Employed (2022 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Return on Capital Employed for 5 consecutive years, with 34.27% the latest figure, recorded in Q1 2026.

  • Quarterly Return on Capital Employed fell 1847.0% year-over-year to 34.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34.27% (down 1847.0% YoY) and the FY2025 annual result came in at 23.04%, down 2669.0% from the prior year.
  • Return on Capital Employed fell to 34.27% in Q1 2026 per VALN's latest filing, from 24.85% in the prior quarter.
  • Over the last five years, Return on Capital Employed for VALN reached as high as 35.31% in Q3 2022 and fell as low as 39.85% in Q2 2022.
  • A 5-year average of 14.43% and a median of 15.8% in 2025 frame the typical range for Return on Capital Employed.
  • The largest YoY upside for Return on Capital Employed was 4046 bps in 2023 against a maximum downside of 7153 bps in 2023.
  • Year by year, Return on Capital Employed stood at 29.67% in 2022, then advanced by 17 bps to 24.77% in 2023, then soared by 114 bps to 3.39% in 2024, then plunged by 834 bps to 24.85% in 2025, then slumped by 38 bps to 34.27% in 2026.
  • According to Business Quant data, Return on Capital Employed over the past three periods registered 34.27%, 24.85%, and 24.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -31.80%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.46%
4 NuCana 279.75 Bn 279.75 Bn - -68.47%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 10.19%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -68.84%
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -34.27%

Historic Data

Download Data
DateValue
Mar 31, 2026 -34.27%
Dec 31, 2025 -24.85%
Sep 30, 2025 -24.14%
Jun 30, 2025 -14.26%
Mar 31, 2025 -15.80%
Dec 31, 2024 3.39%
Sep 30, 2024 2.43%
Jun 30, 2024 -0.12%
Mar 31, 2024 0.74%
Dec 31, 2023 -24.77%
Sep 30, 2023 -36.22%
Jun 30, 2023 0.62%
Mar 31, 2023 -32.59%
Dec 31, 2022 -29.67%
Sep 30, 2022 35.31%
Jun 30, 2022 -39.85%
Mar 31, 2022 -11.21%